CClinicalTrials.gg
TerminatedNCT00574314Updated Apr 10, 2019

Women's Health Research Registry

An observational study in Healthy, sponsored by Cedars-Sinai Medical Center. Terminated at 1 site in United States. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-10.

Sponsored by Cedars-Sinai Medical Center · Observational

Why this study was terminated
No more funding
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
839
Sex
Female
01

Study summary

Women have been disproportionately underrepresented in clinical research. Few of the many drugs approved by the FDA have been adequately tested in women. Most common health conditions experienced by both women and men are managed by treatments that have been developed and tested most in men.

A new barrier to enrolling women in clinical trials is in effect: HIPAA (the Health Insurance Portability and Accountability Act). The positive benefit of HIPAA-protecting a person's health information from abuse-is laudable, but it comes at a cost: it will deny investigators the benefit of access to chart (medical record) review in order to gather data to answer clinical questions. In the past, investigators were allowed access to patient's charts because the hospital consent form included a clause indicating that the patient's information may be used for research.

The investigators propose to overcome this crisis and challenge with a proven method of identifying individuals who would be willing to consider participating in a clinical trial: The Women's Guild Health Research Registry. In keeping with the focus of the Women's Health Program, we would propose to enroll only women. The registry will allow qualified investigators to identify potential study participants. This idea has been effective at improving the quantity and quality of women able and willing to participate in trials.

The investigators will also allow other approved sites to utilize the Registry via the approved procedure of submitting an IRB approved protocol which will be reviewed by our Internal Review Committee. This protocol's inclusion/exclusion criteria will be used to query the database for eligible participants. The participants will be contacted by the Registry staff to ascertain their interest in this research protocol and their agreement to release their contact data to the investigator will be obtained.

Investigators will be charged at the time they approach the registry for assistance. The charge is intended to cover the cost of maintaining the registry now that initial funding has been exhausted.

Read the detailed description

See Brief Summary above

02

Conditions studied

  • Healthy

Keywords

  • women
  • Registry
03

In context

Lead sponsor

Cedars-Sinai Medical Center is the lead sponsor of 441 studies on the registry; 108 are open to participants now.

Of its 62 completed or terminated interventional studies of FDA-regulated products, 47 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All adult English-speaking women

Inclusion criteria

  • Adult women
  • English speaking

Exclusion criteria

Exclusion Criteria:

  • We do not include children.
  • We do not include non-English speaking subjects at this time.
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
839 participants (actual)

Groups and cohorts

  • Women

    Women with varying backgrounds

    Other: No Intervention

Interventions

  • OtherNo Intervention

    Participants will be consented.

06

Study locations

1 site
  • Cedars-Sinai Women's Heart Center
    Los Angeles, California 90048, United States
07

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00574314
Lead sponsor
Cedars-Sinai Medical Center
Responsible party
Noel Bairey Merz (Director, Cedars-Sinai Medical Center) — Principal investigator
First posted
Dec 17, 2007
Start date
Jul 2004
Primary completion
Nov 2012
Completion
Nov 2012
Last update
Apr 10, 2019

Study contacts

C. Noel Bairey Merz, MD
principal investigator · Cedars-Sinai Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion